Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
Copyright® by the International Brazilian Journal of Urology..
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
| Errataetall: |
CommentIn: Int Braz J Urol. 2021 May-Jun;47(3):690-691. - PMID 33621028 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
International braz j urol : official journal of the Brazilian Society of Urology - 46(2020), suppl.1 vom: 18. Juli, Seite 125-132 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gotera, Carolina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 diagnostic testing [Supplementary Concept] |
|---|
| Anmerkungen: |
Date Completed 23.07.2020 Date Revised 01.03.2021 published: Print CommentIn: Int Braz J Urol. 2021 May-Jun;47(3):690-691. - PMID 33621028 Citation Status MEDLINE |
|---|
| doi: |
10.1590/S1677-5538.IBJU.2020.S118 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311294804 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311294804 | ||
| 003 | DE-627 | ||
| 005 | 20231225141939.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1590/S1677-5538.IBJU.2020.S118 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311294804 | ||
| 035 | |a (NLM)32550705 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gotera, Carolina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment and research lines for the patient with COVID-19. What do we have and where are we going? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.07.2020 | ||
| 500 | |a Date Revised 01.03.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Int Braz J Urol. 2021 May-Jun;47(3):690-691. - PMID 33621028 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright® by the International Brazilian Journal of Urology. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 diagnostic testing [Supplementary Concept] | |
| 650 | 4 | |a Patients | |
| 650 | 4 | |a Therapeutics | |
| 773 | 0 | 8 | |i Enthalten in |t International braz j urol : official journal of the Brazilian Society of Urology |d 2002 |g 46(2020), suppl.1 vom: 18. Juli, Seite 125-132 |w (DE-627)NLM152735291 |x 1677-6119 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2020 |g number:suppl.1 |g day:18 |g month:07 |g pages:125-132 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.S118 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2020 |e suppl.1 |b 18 |c 07 |h 125-132 | ||